Cargando…
The generic drug user fee amendments: an economic perspective
Since the vast majority of prescription drugs consumed by Americans are off patent (‘generic’), their regulation and supply is of wide interest. We describe events leading up to the US Congress's 2012 passage of the Generic Drug User Fee Amendments (GDUFA I) as part of the Food and Drug Adminis...
Autores principales: | Berndt, Ernst R, Conti, Rena M, Murphy, Stephen J |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5912081/ https://www.ncbi.nlm.nih.gov/pubmed/29707218 http://dx.doi.org/10.1093/jlb/lsy002 |
Ejemplares similares
-
Health worker perspectives on user fee removal in Zambia
por: Carasso, Barbara S, et al.
Publicado: (2012) -
Abolishing User Fees in Africa
por: Ridde, Valéry, et al.
Publicado: (2009) -
Opportunities and Challenges of Generic Pre-Exposure Prophylaxis Drugs for HIV
por: Ballreich, Jeromie, et al.
Publicado: (2022) -
FDA User Fees Gain Momentum
por: Punzo, Christine
Publicado: (1992) -
Fees
por: Jennings, D. R.
Publicado: (1870)